
1. toxicol vitro. 2019 apr;56:10-18. doi: 10.1016/j.tiv.2018.12.018. epub 2018
dec 30.

toxico-pathological effects meglumine antimoniate human umbilical vein
endothelial cells.

khosravi a(1), sharifi i(2), tavakkoli h(3), keyhani ar(1), afgar a(4), salari
z(5), bamorovat m(1), sharifi f(1), khaleghi t(1), varma rs(6), dabiri s(7),
nematollahi-mahani sn(8), babaee a(9), mostafavi m(1), hakimi parizi m(1),
derakhshanfar a(10), salarkia e(1).

author information: 
(1)leishmaniasis research center, kerman university medical sciences, kerman, 
iran.
(2)leishmaniasis research center, kerman university medical sciences, kerman, 
iran. electronic address: iraj.sharifi@yahoo.com.
(3)department clinical science, school veterinary medicine, shahid bahonar 
university kerman, kerman, iran. electronic address: tavakkoli@uk.ac.ir.
(4)research center hydatid disease iran, kerman university medical
sciences٫ kerman, iran.
(5)obstetrics & gynecology center, afzalipour school medicine, kerman
university medical sciences, kerman, iran.
(6)regional centre advanced technologies materials, faculty science,
palacký university olomouc, šlechtitelů 27, olomouc 783 71, czech republic.
(7)afzalipour school medicine & pathology stem cells research center,
kerman university medical sciences, kerman, iran.
(8)physiology research center, kerman university medical sciences, kerman,
iran.
(9)anatomical sciences department, afzalipour school medicine, kerman
university medical sciences, kerman, iran.
(10)diagnostic laboratory sciences technology research center, school of
paramedical sciences, shiraz university medical sciences, shiraz, iran.

leishmaniasis one important parasitic diseases malaria. 
standard treatment leishmaniasis includes pentavalent antimonials (sbv);
however, drugs associated serious adverse effects. been
very studies pertaining side effects mechanism action 
fetus. investigation examines effects meglumine antimoniate (ma) on
the survival rate, angiogenesis cellular apoptosis human umbilical
vein endothelial cells (huvecs). huvecs treated varying doses ma
(100-800 μg/ml) 24, 48 72 h survival rate studied by
colorimetric assay, flow cytometry, immunocytochemistry, migration (scratch)
assay tube formation assay. results quantitative real-time pcr (qpcr) 
studies indicated important genes involved presenting
angiogenesis included vegf receptors (kdr flt-1), np1 hif-1α
genes including anti-apoptotic gene bcl2, significantly reduced
compared control group (p < 0.05). contrast, leading genes
involved phenomenon apoptosis p53, bax, bak, apaf-1 caspases
3, 8 9, significantly regulated compared control group
(p < 0.05).

copyright © 2019 elsevier ltd. rights reserved.

doi: 10.1016/j.tiv.2018.12.018 
pmid: 30599190  [indexed medline]

